Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hudtwalcker & Co. is a specialized manufacturer and supplier of high-quality marine oils, primarily focusing on cod liver oil and Omega-3 concentrates for the pharmaceutical and nutraceutical industries. Founded in 1743, the company is one of the oldest active entities in the life sciences supply chain, leveraging centuries of expertise in the refinement of fish oils. They provide pharmaceutical-grade active pharmaceutical ingredients (APIs) and excipients, including docosahexaenoic acid and eicosapentaenoic acid, which meet stringent European Pharmacopoeia and USP standards. The company operates out of Norway, maintaining a global distribution network that serves manufacturers of cardiovascular and nutritional health products. Their portfolio includes various grades of refined, winterized, and neutralized oils tailored for human and veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hudtwalcker & Co..